OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 150 filers reported holding OCULAR THERAPEUTIX INC in Q2 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $48,000 | +14.3% | 11,500 | +9.5% | 0.00% | – |
| Q2 2022 | $42,000 | +2000.0% | 10,500 | +2000.0% | 0.00% | – |
| Q1 2022 | $2,000 | -33.3% | 500 | 0.0% | 0.00% | – |
| Q4 2021 | $3,000 | -40.0% | 500 | 0.0% | 0.00% | – |
| Q3 2021 | $5,000 | -28.6% | 500 | 0.0% | 0.00% | – |
| Q2 2021 | $7,000 | -12.5% | 500 | 0.0% | 0.00% | – |
| Q1 2021 | $8,000 | -20.0% | 500 | 0.0% | 0.00% | – |
| Q4 2020 | $10,000 | +150.0% | 500 | 0.0% | 0.00% | – |
| Q3 2020 | $4,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q2 2020 | $4,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 3,784,850 | $15,064,000 | 62.56% |
| Versant Venture Management, LLC | 2,215,384 | $8,817,228,000 | 4.36% |
| SV Health Investors, LLC | 628,236 | $2,500,000 | 1.54% |
| DELTEC ASSET MANAGEMENT LLC | 724,747 | $2,885,000 | 0.80% |
| Endurant Capital Management LP | 232,727 | $926,000 | 0.49% |
| NOTTINGHAM ADVISORS, INC. | 146,946 | $1,011,000 | 0.15% |
| JGP Global Gestao de Recursos Ltda. | 12,568 | $50,000 | 0.06% |
| Man Group plc | 1,187,508 | $4,726,000 | 0.02% |
| Dynamic Technology Lab Private Ltd | 21,077 | $84,000 | 0.02% |
| NewEdge Advisors, LLC | 36,250 | $144,000 | 0.01% |